Central nervous system infections in immunocompromised patients: update on diagnostics and therapy.

Abstract

Infections of the central nervous system (CNS) are increasingly reported in patients with malignancies. Heavily immunocompromised patients like those after allogeneic stem cell transplantation (SCT) or previous T cell depleting treatment regimens (e.g. with fludarabine or alemtuzumab) are at highest risk for cerebral infections. The spectrum of causative… (More)
DOI: 10.1080/10428190802517740

Topics

  • Presentations referencing similar topics